Affiliate disclosure: some links on this page are affiliate links and may earn us a commission at no extra cost to you — it never affects our rankings or reviews.

What Is Peptide Therapy?

Edited by Gabriel BrocklesbyFounder & EditorFact-checked

Peptide therapy is an umbrella term for clinical protocols involving short chains of amino acids that interact with receptors in the body to influence specific biological processes. Unlike conventional pharmaceuticals, peptides are typically derived from or modeled on naturally occurring compounds, which is part of why they have attracted interest from clinicians working in longevity, hormone optimization, and regenerative medicine contexts.

The range of peptides used in clinical settings is broad. Some are associated with growth hormone secretion, others with recovery and tissue repair, weight management, skin health, or cognitive support. Each operates through a distinct mechanism and carries its own evidence base, regulatory status, and risk profile.

Clinics offering peptide therapy vary significantly in how they structure consultations. Some operate concierge or functional medicine models with comprehensive intake assessments, while others offer more transactional access. The quality of clinical oversight, including baseline testing, dosing rationale, and follow-up monitoring, differs widely between providers.

When researching peptide therapy, it is important to distinguish between treatments with established clinical evidence and those that are more experimental. Questions to ask a clinic include: what evidence supports this protocol, who will supervise my treatment, what monitoring is included, and what happens if I experience side effects.

Peptide Clinic Finder is an informational directory. It does not prescribe, recommend, or sell treatments. All listings are published for comparison and research purposes only. Always consult a qualified clinician before pursuing any peptide protocol.

Which peptides are FDA approved in 2026

In the US, "peptide therapy" covers three very different things: FDA-approved prescription medicines, six peptides that a licensed pharmacy may now compound on a prescription under an interim HHS policy, and peptides with no FDA-approved product at all. Here is where each peptide we cover stands. The official record behind every line is on our guide are peptides legal in the US.

FDA-approved peptide medicines

These have at least one FDA-approved product. Each approval is for specific uses, and every one needs a prescription.

  • Semaglutide: FDA approved as Ozempic for type 2 diabetes (2017) and as Wegovy for chronic weight management (2021). Compounded copies are not FDA approved.
  • Tirzepatide: FDA approved as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic weight management (2023). Compounded copies are not FDA approved.
  • Liraglutide: FDA approved as Victoza for type 2 diabetes (2010) and as Saxenda for chronic weight management (2014). A generic was first approved in 2024.
  • Tesamorelin: FDA approved as Egrifta (2010) only to reduce excess abdominal fat in adults with HIV and lipodystrophy.
  • SS-31 (elamipretide): FDA approved as Forzinity (September 2025) under accelerated approval, only to improve muscle strength in Barth syndrome.
  • Sermorelin: Was FDA approved as Geref (1990 and 1997); both products were discontinued, and the FDA determined in 2013 they were not withdrawn for reasons of safety or effectiveness. US telehealth programs prescribe compounded sermorelin, which is not FDA approved.

Covered by the HHS interim compounding policy (October 2026)

No FDA-approved product exists for these six. Since October 2026 an interim HHS policy lets licensed 503A pharmacies compound them on a patient-specific prescription, by the route listed. HHS says the policy does not grant FDA approval or establish safety and effectiveness, and that it may revisit it.

  • BPC-157: No FDA-approved product. Covered by the HHS interim policy for compounding on prescription; covered route: subcutaneous, intramuscular, oral or topical.
  • TB-500: No FDA-approved product. Covered by the HHS interim policy for compounding on prescription; covered route: subcutaneous or intramuscular injection.
  • MOTS-c: No FDA-approved product. Covered by the HHS interim policy for compounding on prescription; covered route: subcutaneous or intramuscular injection.
  • KPV: No FDA-approved product. Covered by the HHS interim policy for compounding on prescription; covered route: topical or oral only.
  • Semax: No FDA-approved product. Covered by the HHS interim policy for compounding on prescription; covered route: intranasal only.
  • Epitalon: No FDA-approved product. Covered by the HHS interim policy for compounding on prescription; covered route: injection, dispensed in intermittent courses.

No FDA-approved product and not covered by the policy

None of these has an FDA-approved product, and none is one of the six peptides in the HHS interim policy.

  • Retatrutide: Investigational. No FDA-approved product; Eli Lilly has said it plans to submit it to the FDA. Products sold online as retatrutide are not approved medicines.
  • Cagrilintide (CagriSema): No FDA-approved product. Novo Nordisk has filed CagriSema (cagrilintide with semaglutide) with the FDA; it is not approved.
  • Survodutide: Investigational. No FDA-approved product.
  • CJC-1295: No FDA-approved product.
  • Ipamorelin: No FDA-approved product.
  • AOD-9604: No FDA-approved product.
  • Thymosin alpha-1: No FDA-approved product.
  • Selank: No FDA-approved product.
  • GHK-Cu: No FDA-approved drug product.
  • DSIP: No FDA-approved product.

What peptide therapy costs in the US

Cost depends on the peptide and on who prescribes it. The most common peptide treatments online are the GLP-1 medicines, which US online programs sell as brand-name or compounded plans; compounded medicines are not FDA approved. Every price we track, brand and compounded, is on the US GLP-1 price index. Sermorelin and the six policy peptides are priced in our guides to each.

Questions to ask any peptide therapy provider

  • Is this peptide an FDA-approved medicine, or is it compounded? If compounded, which licensed pharmacy makes it?
  • Who prescribes it, and is that clinician licensed in my state?
  • What is the full monthly cost, including any membership or consultation fee, and how do cancellation and refunds work?
  • For a product sold without a prescription or labeled "for research use only": it is not an approved medicine for people.

To compare providers near you, see peptide therapy clinics.

Frequently asked questions

What is peptide therapy?

Peptide therapy involves the use of short amino acid chains that interact with receptors in the body to influence specific biological processes including recovery, hormone regulation, and metabolic health.

Is peptide therapy safe?

Safety varies significantly depending on the specific peptide, dosing, and individual health profile. Always consult a licensed clinician and verify credentials before pursuing any peptide protocol.

How do I find a peptide therapy clinic?

Peptide Clinic Finder is a global directory of peptide and longevity clinics. Use the search and filter tools to find providers in your location and send direct inquiries.

Next step

Compare clinics offering this treatment

Use city pages, treatment comparisons, and clinic listings together. That gives you a better view of program quality, pricing context, and oversight than reading a guide in isolation.

Continue researching

Curated pricing and clinic research

Compare GLP-1 providers

For clinics

Are you a clinic?

Get featured on this page and reach patients actively looking for peptide therapy, GLP-1 treatments, recovery support, and longevity care.